Streetbeat News

Stock Prices

ALLR

Allarity Therapeutics has received a formal extension until April 24, 2024, to meet Nasdaq's listing compliance requirements. This extension provides the company additional time to address and rectify the issues that led to the non-compliance notice.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:50 am

SLRX

Salarius Pharmaceuticals' shares surged following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:45 am

REGN

Regeneron's stock trades lower following FDA's Complete Response Letters for odronextamab Biologics License Application, citing issues with confirmatory trials' enrollment status.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:44 am

AMD

INTC

MASI

QQQ

SPY

TSLA

UAL

Wall Street is expected to open lower, influenced by concerns over China's plan to exclude U.S. chipmakers from government PCs and servers, and anticipation of Federal Reserve speeches. Last week, the market saw a recovery after the Fed hinted at possible rate cuts, but ended with slight retreats. Analysts offer mixed views, with some predicting a correction and others remaining bullish. Premarket trading saw declines in major ETFs and companies like AMD, INTC, and TSLA, while MASI surged on news of an upcoming proxy battle.

Portfolio Pulse from Shanthi Rexaline

March 25, 2024 | 11:40 am

SPG

Truist Securities analyst Ki Bin Kim maintains a Hold rating on Simon Property Group (NYSE:SPG) and raises the price target from $139 to $147.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:39 am

PRGS

Progress Software Corporation (NASDAQ:PRGS) is anticipated to report lower earnings for Q1 on March 26, 2024, with an expected EPS of $1.14, down from $1.19 year-over-year. Revenue is projected at $181.91 million. The company recently priced a $400 million convertible senior notes offering. Shares dropped 0.8% to $52.48. Analysts from Wedbush, Oppenheimer, Citigroup, Guggenheim, and JP Morgan have provided ratings and price targets, with the most recent being a price target increase from Wedbush to $67.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 11:38 am

FTHM

HHH

Howard Hughes Holdings Inc. (HHH) and Fathom Holdings Inc. (FTHM) are highlighted as the top 2 oversold real estate stocks, potentially undervalued. HHH reported better-than-expected Q4 earnings, while FTHM posted downbeat quarterly results. Both stocks have an RSI below 30, indicating they may be oversold and could see a price rebound.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 11:37 am

VERO

Venus Concept announced that the Nasdaq Hearings Panel has granted its request for continued listing on the Nasdaq Capital Market. This decision allows the company to maintain its presence on the exchange, subject to compliance with certain conditions.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:37 am

MASI

Masmi shares are trading higher following the company's announcement that it has authorized management to evaluate a proposed separation of its consumer business.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:36 am

AAPL

VGT

XLK

Apple Inc (AAPL) is planning to launch its Vision Pro headset in China within the year, as announced by CEO Tim Cook. The headset, priced at $3,500 in the US, marks Apple's entry into the virtual and augmented reality market. Despite a 24% drop in iPhone sales in China and a 13% decrease in revenue to $20.8 billion in the December quarter, Apple remains optimistic about the Chinese market. The stock can be accessed through ETFs like Vanguard Information Tech ETF (VGT) and SPDR Select Sector Fund - Technology (XLK). AAPL shares saw a slight decrease of 0.35% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 25, 2024 | 11:34 am